Home > Insider Trading > Filing (0001225208-14-025381)

Filing Details

Accession Number:: 0001225208-14-025381
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-17 18:15:17
Reporting Period:: 2014-12-15

Filing Date:: 2014-12-17
Accepted Time:: 2014-12-17 18:15:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403373	A John Deford	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	Sr. Vp Sci Tech And Clin Afrs	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-12-15	2,656	$166.63	24,872	No	4	F	Direct
Common Stock	Acquisiton	2014-12-16	5,626	$84.58	30,498	No	4	M	Direct
Common Stock	Disposition	2014-12-16	400	$168.50	30,098	No	4	S	Direct
Common Stock	Disposition	2014-12-16	1,547	$166.69	28,551	No	4	S	Direct
Common Stock	Disposition	2014-12-16	3,679	$167.69	24,872	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2014-12-16	5,626	$0.00	5,626	$84.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,627		2021-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	35	Indirect	401(k) Plan

Footnotes

Shares withheld to pay taxes upon vesting of restricted stock units granted under the Company's 2003 Long Term Incentive Plan.
Includes 0.2256 shares acquired under the Company's Dividend Reinvestment Plan from February 11, 2014 to October 31, 2014.
Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Represents the weighted average sales price for price increments ranging from $168.15 to $168.94. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $166.13 to $167.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $167.14 to $168.13. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 20.921 shares acquired under the Company's 401(k) Plan from February 4, 2014 to October 31, 2014.
Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this option grant 5,627 options are fully vested, and the remaining 5,627 options will vest on December 14, 2015.